Cargando…
Review of preclinical data of PF-07304814 and its active metabolite derivatives against SARS-CoV-2 infection
Main protease (M(pro)) is a superior target for anti-SARS-COV-2 drugs. PF-07304814 is a phosphate ester prodrug of PF-00835231 that is rapidly metabolized into the active metabolite PF-00835231 by alkaline phosphatase (ALP) and then suppresses SARS-CoV-2 replication by inhibiting M(pro). PF-07304814...
Autores principales: | Chen, Wujun, Shao, Yingchun, Peng, Xiaojin, Liang, Bing, Xu, Jiazhen, Xing, Dongming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9691842/ https://www.ncbi.nlm.nih.gov/pubmed/36438815 http://dx.doi.org/10.3389/fphar.2022.1035969 |
Ejemplares similares
-
Crystal structures of main protease (M(pro)) mutants of SARS-CoV-2 variants bound to PF-07304814
por: Jiang, Haihai, et al.
Publicado: (2023) -
Structural Basis of Main Proteases of Coronavirus Bound to Drug Candidate PF-07304814
por: Li, Jian, et al.
Publicado: (2022) -
Structural basis of main proteases of HCoV-229E bound to inhibitor PF-07304814 and PF-07321332
por: Zhou, Yanru, et al.
Publicado: (2023) -
Safety, Tolerability, and Pharmacokinetics of Single and Multiple Ascending Intravenous Infusions of PF-07304814 (Lufotrelvir) in Participants Hospitalized With COVID-19
por: Robinson, Philip, et al.
Publicado: (2023) -
Advances and challenges in using nirmatrelvir and its derivatives against SARS-CoV-2 infection
por: Chen, Wujun, et al.
Publicado: (2023)